BR0007503A - Mistura farmacêutica - Google Patents

Mistura farmacêutica

Info

Publication number
BR0007503A
BR0007503A BR0007503-5A BR0007503A BR0007503A BR 0007503 A BR0007503 A BR 0007503A BR 0007503 A BR0007503 A BR 0007503A BR 0007503 A BR0007503 A BR 0007503A
Authority
BR
Brazil
Prior art keywords
pharmaceutical mixture
profen
pharmaceutical
mixture
disintegrator
Prior art date
Application number
BR0007503-5A
Other languages
English (en)
Inventor
Heinz Einig
Harald Hach
Raymond Eason
Bernd W Mueller
Richard C Thompson
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR0007503A publication Critical patent/BR0007503A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Engine Equipment That Uses Special Cycles (AREA)

Abstract

"MISTURA FARMACêUTICA". é descrita uma mistura farmacêutica que compreende um profen e um ou mais compostos ativos adicionais, que tem um teor total de composto ativo acima de 85% e contém até 1%, baseado no teor do profen, de um tensoativo não iónico que tem um HLB <242> 9 e um desintegrador e um lubrificante costumeiros.
BR0007503-5A 1999-01-14 2000-01-07 Mistura farmacêutica BR0007503A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/245,112 US6251945B1 (en) 1999-01-14 1999-01-14 Pharmaceutical mixture comprising a combination of a profen and other active compounds
PCT/EP2000/000054 WO2000041680A1 (en) 1999-01-14 2000-01-07 Pharmaceutical mixture comprising a combination of a profen and other active compounds

Publications (1)

Publication Number Publication Date
BR0007503A true BR0007503A (pt) 2002-01-08

Family

ID=22925340

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007503-5A BR0007503A (pt) 1999-01-14 2000-01-07 Mistura farmacêutica

Country Status (22)

Country Link
US (1) US6251945B1 (pt)
EP (1) EP1128820B1 (pt)
JP (1) JP2002534457A (pt)
KR (1) KR20010101521A (pt)
CN (1) CN1188113C (pt)
AT (1) ATE263547T1 (pt)
AU (1) AU771574B2 (pt)
BR (1) BR0007503A (pt)
CA (1) CA2360227A1 (pt)
CZ (1) CZ20012553A3 (pt)
DE (1) DE60009652T2 (pt)
DK (1) DK1128820T3 (pt)
ES (1) ES2218138T3 (pt)
HU (1) HUP0105097A3 (pt)
IL (2) IL144006A0 (pt)
MX (1) MXPA01006791A (pt)
NO (1) NO20013499L (pt)
PT (1) PT1128820E (pt)
RU (1) RU2001122815A (pt)
TW (1) TWI222883B (pt)
WO (1) WO2000041680A1 (pt)
ZA (1) ZA200106625B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726929B1 (en) * 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
US9248101B2 (en) * 2005-04-13 2016-02-02 Abbvie Deutschland Gmbh & Co Kg Method for the gentle production of ultrafine particle suspensions and ultrafine particles and the use thereof
ES2380747T3 (es) 2006-07-18 2012-05-18 Horizon Pharma Usa, Inc. Métodos y medicamentos para administración de ibuprofeno
DE102007001473A1 (de) 2007-01-08 2008-07-10 Andreas Lemke Verfahren zur Herstellung und Anwendung von Mikro- und/oder Nanosuspensionen durch aufbauende Mikronisierung in Gegenwart von Trockeneis und hohem Druck
TR201710637T1 (tr) * 2015-02-10 2018-04-24 Pharmactive Ilac Sanayi Ve Ticaret Anonim Sirketi Ibuprofen, psödoefedri̇n ve vi̇tami̇n c i̇çeren bi̇r farmasöti̇k kompozi̇syon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
US4587252A (en) * 1984-12-18 1986-05-06 Brighton Pharmaceutical, Inc. Hydrocodone/ibuprofen pharmaceutical compositions and method
ATE92752T1 (de) * 1987-07-08 1993-08-15 American Home Prod Spruehgetrocknete ibuprofen-zusammensetzungen.
US4837031A (en) 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4911921A (en) 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
CA2144152A1 (en) * 1992-09-29 1994-04-14 Robert T. Sims Ibuprofen-caffine combinations
ATE180668T1 (de) 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel

Also Published As

Publication number Publication date
EP1128820B1 (en) 2004-04-07
TWI222883B (en) 2004-11-01
HUP0105097A2 (en) 2002-06-29
NO20013499L (no) 2001-09-10
EP1128820A1 (en) 2001-09-05
DK1128820T3 (da) 2004-08-09
AU771574B2 (en) 2004-03-25
ATE263547T1 (de) 2004-04-15
CA2360227A1 (en) 2000-07-20
CN1336819A (zh) 2002-02-20
KR20010101521A (ko) 2001-11-14
CZ20012553A3 (cs) 2001-10-17
WO2000041680A1 (en) 2000-07-20
IL144006A0 (en) 2002-04-21
DE60009652T2 (de) 2005-03-24
DE60009652D1 (de) 2004-05-13
PT1128820E (pt) 2004-07-30
NO20013499D0 (no) 2001-07-13
IL144006A (en) 2006-08-20
CN1188113C (zh) 2005-02-09
RU2001122815A (ru) 2004-02-20
AU3420600A (en) 2000-08-01
ZA200106625B (en) 2002-08-13
HUP0105097A3 (en) 2006-07-28
ES2218138T3 (es) 2004-11-16
JP2002534457A (ja) 2002-10-15
MXPA01006791A (es) 2003-07-14
US6251945B1 (en) 2001-06-26

Similar Documents

Publication Publication Date Title
BR0006005A (pt) Composição estável de óleo em glicerinatopicamente aplicável
PT986403E (pt) Composicao com um tempo de vida de armazenagem prolongado compreendendo a ciclodextrina e drogas ou prodrogas que se decompoem em compostos insoluveis em agua
BR9810634A (pt) Composições detergente lìquidas estruturadas,contendo ácido graxo, não-aquosas
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
BR0016166A (pt) Compostos de diidropirimidina heterocìclicos
BR0016665A (pt) Composição alvejante, e, métodos de alvejamento e de preparação de uma composição alvejante
DE69727922D1 (de) Schnell zerfallende orale dosierungsform
BR9812313A (pt) Sistema de liberação controlada de lìquido de viscosidade elevada como um dispositivo
CA2319810A1 (en) Propofol composition containing sulfite
BR0200381A (pt) Produção de resinas de polipropileno de ultra alta fluidez em fusão
BR9809865A (pt) Fixador de perfume, perfume e produto base misturados com o mesmo, e, produto perfumado.
BR9913738A (pt) Composições e métodos de sanitização
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
BR0007503A (pt) Mistura farmacêutica
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
BR0110833A (pt) Uma composição de agente de redução de fricção
KR970074763A (ko) 불소화된 비타민 d₃ 유사체
BR0013625A (pt) Composição para uso no tratamento de carcinoma hepatocelular
CA2305933A1 (fr) Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
BR0000544A (pt) Poliolefinas de metaloceno estabilizadas
DE69704833T2 (de) Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
BR9910386A (pt) Composição de um aditivo de combustìvel
BR9803730A (pt) Preparados farmacêuticos de cilansetron estabilizados contra a racemização.
BR9901955A (pt) Associação, composição cosmética e/ou dermatológica, utilização de pelo menos um derivado de histidina, processo para aperfeiçoar a estabilidade de uma composição, utilização de uma associação e de uma composição cosmética, processo de tratamento cosmético e composição dermatológica
BR0212259A (pt) Formulação de liberação controlada de claritromicina ou tinidazol

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]